Literature DB >> 8849573

FSH isoforms: bio and immuno-activities in post-menopausal and normal menstruating women.

S Creus1, E Pellizzari, S B Cigorraga, S Campo.   

Abstract

OBJECTIVE: The full expression of gonadotrophin biological activity depends on the gonadotrophin carbohydrate component. Our aim was to study serum FSH isoforms present in the follicular phase (FPS) and in the menopause (PMS) since the endocrine status may influence the structure of incorporated oligosaccharides.
SUBJECTS: Ten healthy post-menopausal women (age range 53-68) not receiving any hormonal treatment and 10 healthy women (age range 20-28) in the follicular phase of their menstrual cycle were studied. MEASUREMENTS: Bio and immuno FSH-activities (Sertoli cell aromatase induction assay and RIA, respectively) were determined in separated isoforms after concanavalin A chromatography. Isolated isoforms were: UB, unbound; WB, weakly bound and FB, firmly bound to the lectin.
RESULTS: PMS showed two groups of immuno and bio-active FSH isoforms: WB, bearing biantennary galactosylated type and FB, bearing high mannose or hybrid type oligosaccharides. Immuno and bio-active FSH were not detected in the UB fractions. WB isoforms represented 82 +/- 6% of the total bioactivity recovered in samples analysed individually; their B/I ratio was 0.85 +/- 0.20. FB isoforms were 18 +/- 6%; their B/I ratio was 3.27 +/- 0.60. Whole serum B/I ratio was 1.20 +/- 0.30. Similar results were obtained when pooled sera was analysed: WB: 77%, B/I: 0.82; FB: 23%, B/I: 3.75. Whole serum B/I in pooled samples was 1.10. FPS showed a different pattern. UB isoforms, bearing triantennary or bisecting oligosaccharides, were 41 +/- 3% of the total bioactivity recovered in samples analysed individually. Their B/I ratio was 0.61 +/- 0.23. WB isoforms were 59 +/- 3% and their B/I 0.76 +/- 0.14. FB FSH isoforms were not detected. The whole serum B/I ratio was 0.60 +/- 0.30. Similar results were obtained when pooled sera was analysed: WB 43%, B/I 0.42; FB 57%, B/I 0.62. Whole serum B/I in pooled samples was 0.70.
CONCLUSIONS: These results show that, in normal women, circulating FSH bioactivity is associated with isoforms with different oligosaccharide [correction of oligosacharide] structures according to hormonal status. FSH in the follicular phase has a higher degree of branching and a more complete carbohydrate chain than the FSH secreted during the menopause.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849573     DOI: 10.1046/j.1365-2265.1996.646467.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  A human FSHB transgene encoding the double N-glycosylation mutant (Asn(7Δ) Asn(24Δ)) FSHβ subunit fails to rescue Fshb null mice.

Authors:  Huizhen Wang; Vladimir Butnev; George R Bousfield; T Rajendra Kumar
Journal:  Mol Cell Endocrinol       Date:  2016-02-19       Impact factor: 4.102

Review 2.  Follicle-Stimulating Hormone Glycobiology.

Authors:  George R Bousfield; David J Harvey
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

3.  In vitro ovarian follicle growth: a comprehensive analysis of key protocol variables†.

Authors:  Leah E Simon; T Rajendra Kumar; Francesca E Duncan
Journal:  Biol Reprod       Date:  2020-08-21       Impact factor: 4.285

4.  Evaluation of in vivo bioactivities of recombinant hypo- (FSH21/18) and fully- (FSH24) glycosylated human FSH glycoforms in Fshb null mice.

Authors:  Huizhen Wang; Jacob May; Viktor Butnev; Bin Shuai; Jeffrey V May; George R Bousfield; T Rajendra Kumar
Journal:  Mol Cell Endocrinol       Date:  2016-08-22       Impact factor: 4.102

5.  In vitro biological-to-immunological ratio of serum gonadotropins throughout male puberty in children with insulin-dependent diabetes mellitus.

Authors:  Elisa Nishimura; Daniela Söderlund; Cecilia Castro-Fernández; Teresa Zariñán; Juan Pablo Méndez; Alfredo Ulloa-Aguirre
Journal:  Endocrine       Date:  2007-02       Impact factor: 3.633

6.  Efficacy of native and hyperglycosylated follicle-stimulating hormone analogs for promoting fertility in female mice.

Authors:  Rhonda K Trousdale; Bo Yu; Susan V Pollak; Nabil Husami; Andrea Vidali; Joyce W Lustbader
Journal:  Fertil Steril       Date:  2008-02-04       Impact factor: 7.329

7.  Ovotoxic effects of galactose involve attenuation of follicle-stimulating hormone bioactivity and up-regulation of granulosa cell p53 expression.

Authors:  Sayani Banerjee; Pratip Chakraborty; Piyali Saha; Soma Aditya Bandyopadhyay; Sutapa Banerjee; Syed N Kabir
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.